生物标志物:从早期检测到治疗个性化
Saman Fatima1, Sakshi Tiwari2, Bilal Siddiqi2
1Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India.
Progress in brain research
|November 28, 2025
概括
生物标志物对于早期检测和个性化治疗神经退行性疾病 (NDs) 至关重要,如阿尔茨海默氏症和帕金森氏症. 研究重点是流体,成像和分子生物标志物,以更好地诊断和管理.
科学领域:
- 神经学 神经学
- 生物标志物研究 生物标志物研究
- 精准医学是一门精准的医学.
背景情况:
- 像阿尔茨海默氏症 (AD),帕金森氏症 (PD) 和ALS这样的神经退行性疾病 (NDs) 由于全球人口老龄化而越来越令人担忧.
- 无病症的社会经济影响需要改进的诊断和治疗策略.
- 目前的诊断方法,如CSF分析和脑成像,可能是侵入性的.
研究的目的:
- 探索生物标志物在早期检测,监测和个性化治疗NDs中的关键作用.
- 为了分类不同类型的生物标记物,包括流体,数字成像和分子标记物.
- 在ND中审查关键蛋白质病变的病理生理学和诊断含义 (tau,粉胺-β,α-synuclein,TDP-43).
主要方法:
- 关于神经退行性疾病生物标志物的当前文献的综述.
- 生物标志物的分类基于类型 (流体,成像,分子).
- 在ND中分析蛋白质沉积模式 (陶,粉胺-β,α-同核素,TDP-43).
主要成果:
- 生物标志物是精准医学的重要工具,可用于早期检测和量身定制的治疗计划.
- 关键蛋白质如tau和粉样β的共同沉积在ND中很常见,这给诊断带来了挑战.
- 最近的研究重点是血液血清和脑脊液中的体内生物标志物.
结论:
- 生物标志物正在改变神经退行性疾病管理的格局.
- 跨学科的研究和技术进步对于未来的生物标志物驱动精密医学至关重要.
- 了解复杂的蛋白质病变是改善临床病理学意义和患者结果的关键.
更多相关视频
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
18.2K
08:27Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
15.2K
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
01:16Therapeutic Drug Monitoring: Overview and Classification
275
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
275
01:24Dosage Regimen: Individualization
154
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
154
02:18Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K